- Investing Ideas
- /
- German Pharmaceuticals & Biotech Potentially Undervalued Companies
German Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
455
Companies with a Value score of at least 3, ordered by Value score
455 companies
Spectrum Pharmaceuticals
Market Cap: €209.9m
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.
NTR
€0.93
7D
0.5%
1Y
11.6%
Teva Pharmaceutical Industries
Market Cap: €19.5b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEV
€15.65
7D
6.1%
1Y
1.0%
Amneal Pharmaceuticals
Market Cap: €2.2b
A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.
2DT
€6.30
7D
-3.1%
1Y
6.8%
Indivior
Market Cap: €1.1b
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
2IVB
€9.90
7D
-0.5%
1Y
-41.1%
Royalty Pharma
Market Cap: €18.2b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPD
€28.17
7D
-3.0%
1Y
16.9%
Otsuka Holdings
Market Cap: €3.6t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
OS1
€41.60
7D
3.5%
1Y
16.2%
Bristol-Myers Squibb
Market Cap: €95.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BRM
€41.39
7D
-1.6%
1Y
10.1%
Merck
Market Cap: €194.8b
Operates as a healthcare company worldwide.
6MK
€68.40
7D
-0.7%
1Y
-41.1%
Merck KGaA
Market Cap: €50.9b
Operates as a science and technology company in Germany.
MRK
€115.35
7D
-2.0%
1Y
-31.5%
Bristol-Myers Squibb
Market Cap: €95.3b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BRM
€41.58
7D
-2.1%
1Y
11.4%
Genomma Lab Internacional. de
Market Cap: €20.7b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
GEKA
€0.94
7D
-2.1%
1Y
5.6%
Merck KGaA
Market Cap: €50.9b
Operates as a science and technology company in Germany.
MRK
€116.70
7D
0.2%
1Y
-31.0%
Amphastar Pharmaceuticals
Market Cap: €1.2b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
29A
€21.19
7D
-1.4%
1Y
-46.2%
Catalyst Pharmaceuticals
Market Cap: €3.0b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CN2
€21.37
7D
-0.3%
1Y
47.7%
ICON
Market Cap: €10.2b
A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
IJF
€112.00
7D
-3.5%
1Y
-61.9%
Merck
Market Cap: €194.8b
Operates as a healthcare company worldwide.
6MK
€68.00
7D
-1.2%
1Y
-41.7%
Goodbody Health
Market Cap: €1.3m
Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.
A3DTP0
€0.085
7D
0%
1Y
-83.0%
Tilray Brands
Market Cap: €442.2m
A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.
2HQ
€0.39
7D
-3.7%
1Y
-76.6%
ACADIA Pharmaceuticals
Market Cap: €3.7b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
DR6
€19.31
7D
-1.8%
1Y
38.2%
Viatris
Market Cap: €9.7b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VIA
€7.56
7D
-3.6%
1Y
-21.2%
Gossamer Bio
Market Cap: €272.8m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.
4GB
€1.03
7D
8.9%
1Y
85.4%
Mirum Pharmaceuticals
Market Cap: €2.2b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
08D
€37.80
7D
-1.6%
1Y
70.3%
Merck KGaA
Market Cap: €50.9b
Operates as a science and technology company in Germany.
MRKC
€22.60
7D
0%
1Y
-31.1%
Fortrea Holdings
Market Cap: €367.6m
A contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
K67
€3.58
7D
-6.8%
1Y
-84.4%
Perrigo
Market Cap: €3.7b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PIG
€23.40
7D
-3.7%
1Y
-8.2%
Grand Pharmaceutical Group
Market Cap: €31.4b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
MX6A
€0.97
7D
6.0%
1Y
77.3%
Johnson & Johnson
Market Cap: €368.0b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ0
€12.50
7D
0.8%
1Y
-3.1%
TerrAscend
Market Cap: €199.6m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TED
€0.33
7D
9.3%
1Y
-77.1%
Sanofi
Market Cap: €113.1b
A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
SNW
€93.30
7D
-0.5%
1Y
5.0%
Regeneron Pharmaceuticals
Market Cap: €62.2b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
RGO
€520.60
7D
-0.8%
1Y
-42.2%
GSK
Market Cap: €58.7b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GS70
€34.40
7D
2.4%
1Y
-15.3%
Bayer
Market Cap: €24.5b
Operates as a life science company worldwide.
BAYN
€25.00
7D
5.8%
1Y
-7.6%
GSK
Market Cap: €58.7b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GS71
€17.37
7D
2.5%
1Y
-14.7%
Viatris
Market Cap: €10.1b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VIA
€7.56
7D
-1.7%
1Y
-20.6%
Novo Nordisk
Market Cap: €2.1t
Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.
NOV
€60.83
7D
-0.8%
1Y
-50.4%
Shionogi
Market Cap: €2.0t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.
SH00
€7.10
7D
0%
1Y
3.4%